News tagged with immune control
Pneumonia wonder drug: Zinc saves lives
Respiratory tract infections, including pneumonia, are the most common cause of death in children under the age of five. In a study looking at children given standard antibiotic therapy, new research published in BioMed Central's ...
Feb 08, 2012 |
5 / 5 (1) |
0
US recommends routine HPV vaccination for boys
US health authorities on Friday urged all boys age 11-12 to get a routine vaccination against the most common sexually transmitted disease, human papillomavirus, or HPV.
Feb 03, 2012 |
5 / 5 (1) |
0
Unveiling malaria's 'invisibility cloak'
The discovery by researchers from the Walter and Eliza Hall Institute of a molecule that is key to malaria's 'invisibility cloak' will help to better understand how the parasite causes disease and escapes from the defenses ...
Jan 18, 2012 |
5 / 5 (1) |
0
|
HIV drug reduces graft-versus-host disease in stem cell transplant patients
An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood cancer patients following allogeneic stem cell transplantation (ASCT), according ...
Dec 13, 2011 |
not rated yet |
1
Stronger flu shots, more side effects
Ordinary flu vaccine has always worked out for Carolyn Hendrickson, so the 77-year-old was perplexed on a recent Monday when her clinic gave her a high-dose version without asking first.
Medicine & Health / Medications
Nov 11, 2011 |
not rated yet |
0
Panel: Boys should get HPV vaccine given to girls
(AP) -- A vaccine against cervical cancer hasn't been all that popular for girls. It may be even a harder sell for boys now that it's been recommended for them too.
Oct 25, 2011 |
4 / 5 (4) |
5
Researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine
An experimental vaccine developed by researchers at the University of Pennsylvania's schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for ...
Oct 18, 2011 |
5 / 5 (4) |
0
|
Experimental vaccine protects monkeys from blinding trachoma
An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a Nati ...
Oct 10, 2011 |
not rated yet |
0
|
Cantaloupe outbreak is deadliest in a decade
(AP) -- Health officials say as many as 16 people have died from possible listeria illnesses traced to Colorado cantaloupes, the deadliest food outbreak in more than a decade.
Sep 28, 2011 |
not rated yet |
1
Killer US cantaloupes expected to infect more people
Cantaloupes infected with listeria have sparked the deadliest US foodborne disease outbreak in over a decade and are likely to claim more victims in the weeks ahead, officials said Wednesday.
Sep 28, 2011 |
3.5 / 5 (2) |
0
Stem cells, potential source of cancer-fighting T cells
Adult stem cells from mice converted to antigen-specific T cells -- the immune cells that fight cancer tumor cells -- show promise in cancer immunotherapy and may lead to a simpler, more efficient way to use the body's immune ...
Sep 20, 2011 |
5 / 5 (1) |
0
|
Mexican papayas sicken 99 in US
Mexican papayas tainted with salmonella have sickened 99 people in the United States, the Centers for Disease Control and Prevention said on Tuesday.
Jul 26, 2011 |
5 / 5 (2) |
0
Hepatitis B vaccination for health care students lags behind recommendations
A study in the August issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), suggests that documentation of hepatitis B vaccination for health care s ...
Jul 21, 2011 |
not rated yet |
0
|
Survivors of Joplin tornado develop rare infection
(AP) -- In the aftermath of the Joplin tornado, some people injured in the storm developed a rare and sometimes fatal fungal infection so aggressive that it turned their tissue black and caused mold to grow ...
Jun 11, 2011 |
3 / 5 (2) |
1
ASCO: Experimental vaccine made from frozen immune cells shows promise for prostate cancer patients
Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from ...
Jun 02, 2011 |
not rated yet |
0
